Home  /  Investors   /  Press releases

Press releases

Here you will find all press releases from XVIVO.

Showing 1 to 30 out of 31 posts.
21 Nov, 2016
XVIVO Perfusion has been approved for listing on Nasdaq Stockholm and publishes prospectus
27 Oct, 2016
Clarification of news about two LS™ contract signed in Spain
27 Oct, 2016
XVIVO Perfusion Interim report January – September 2016
27 Oct, 2016
Two LS™ contract signed in Spain
21 Oct, 2016
Conference call on Interim Report
20 Sep, 2016
Election Committee of XVIVO Perfusion AB (publ)
15 Jul, 2016
XVIVO Perfusion Interim report January – June 2016
15 Jul, 2016
Extension of the acceptance period of XVIVO Perfusion’s public offer on Vivoline Medical has ended
8 Jul, 2016
Conference call on Interim Report
8 Jul, 2016
Share warrant program fully subscribed
22 Jun, 2016
Lung Cancer Patient given Chemotherapy through In Vivo Lung Perfusion with STEEN Solution™
21 Jun, 2016
XVIVO Perfusion extends the acceptance period for the public offer on Vivoline Medical
17 Jun, 2016
XPS™ contract signed with leading hospital in Alabama
15 Jun, 2016
First patient in PrimECC study included
8 Jun, 2016
XVIVO Perfusion declares the public offer on Vivoline Medical unconditional, announces the outcome and extends the acceptance period
17 May, 2016
Conference call regarding information on the offer made to Vivoline’s shareholders
10 May, 2016
XVIVO Perfusion published prospectus regarding the public offer to the holders of shares and warrants of series 2015/2016 in Vivoline Medical
4 May, 2016
Report from Annual General Meeting of XVIVO Perfusion AB (publ)
26 Apr, 2016
XVIVO Perfusion Interim report January – March 2016
22 Apr, 2016
Conference call on Interim Report
18 Apr, 2016
XVIVO Perfusion announces a recommended public offer to the holders of shares and warrants of series 2015/2016 in Vivoline Medical
15 Apr, 2016
XPS™ contract signed with leading hospital in Boston
11 Apr, 2016
Annual Report 2015
31 Mar, 2016
Annual General Meeting of XVIVO Perfusion AB (publ)
24 Feb, 2016
XPS™ to be delivered to the first clinic in France
16 Feb, 2016
PERFADEX® and STEEN Solution™ approved in Russia
5 Feb, 2016
XVIVO Perfusion AB admitted to trading on Nasdaq First North Premier
4 Feb, 2016
Report on operations 2015
29 Jan, 2016
XPS™ to Switzerland
28 Jan, 2016
Conference call on Report on Operations 2015

Fill out the form to watch the video